Literature DB >> 15105424

Carboxyl ester lipase cofractionates with scavenger receptor BI in hepatocyte lipid rafts and enhances selective uptake and hydrolysis of cholesteryl esters from HDL3.

Lisa M Camarota1, Jamie M Chapman, David Y Hui, Philip N Howles.   

Abstract

Cholesteryl esters are selectively removed from high density lipoproteins by hepatocytes and steroidogenic cells through a process mediated by scavenger receptor BI. In the liver this cholesterol is secreted into bile, primarily as free cholesterol. Previous work showed that carboxyl ester lipase enhanced selective uptake of cholesteryl ether from high density lipoprotein by an unknown mechanism. Experiments were performed to determine whether carboxyl ester lipase plays a role in scavenger receptor BI-mediated selective uptake. When added to cultures of HepG2 cells, carboxyl ester lipase cofractionated with scavenger receptor BI and [(3)H]cholesteryl ether-labeled high density lipoprotein in lipid raft fractions of cell homogenates. Confocal microscopy of immunostained carboxyl ester lipase and scavenger receptor BI showed a close association of these proteins in HepG2 cells. The enzyme and receptor also cofractionated from homogenates of mouse liver using two different fractionation methods. Antibodies that block scavenger receptor BI function prevented carboxyl ester lipase stimulation of selective uptake in primary hepatocytes from carboxyl ester lipase knockout mice. Heparin blockage of cell-surface proteoglycans also prevented carboxyl ester lipase stimulation of cholesteryl ester uptake by HepG2 cells. Inhibition of carboxyl ester lipase activity in HepG2 cells reduced hydrolysis of high density lipoprotein-cholesteryl esters approximately 40%. In vivo, hydrolysis was similarly reduced in lipid rafts from the livers of carboxyl ester lipase-null mice compared with control animals. Primary hepatocytes from these mice yielded similar results. The data suggest that carboxyl ester lipase plays a physiological role in hepatic selective uptake and metabolism of high density lipoprotein cholesteryl esters by direct and indirect interactions with the scavenger receptor BI pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105424     DOI: 10.1074/jbc.M402946200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Rat carboxylesterase ES-4 enzyme functions as a major hepatic neutral cholesteryl ester hydrolase.

Authors:  Saj Parathath; Snjezana Dogan; Victor A Joaquin; Snigdha Ghosh; Liang Guo; Ginny L Weibel; George H Rothblat; Earl H Harrison; Edward A Fisher
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  SR-BI and protein-protein interactions in hepatic high density lipoprotein metabolism.

Authors:  David L Silver
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Kathryn E Marqueen; Rachel Osborne; Genta Kakiyama; William Korzun; Siddhartha S Ghosh; Shobha Ghosh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-06       Impact factor: 8.311

4.  Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice.

Authors:  Lisa M Camarota; Laura A Woollett; Philip N Howles
Journal:  FASEB J       Date:  2011-01-06       Impact factor: 5.191

5.  Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation.

Authors:  Paweł Burchardt; Jakub Zurawski; Bartosz Zuchowski; Tomasz Kubacki; Dawid Murawa; Krzysztof Wiktorowicz; Henryk Wysocki
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

6.  Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.

Authors:  Clemens Röhrl; Karin Eigner; Stefanie Fruhwürth; Herbert Stangl
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

7.  Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.

Authors:  J Shen; H Tsoi; Q Liang; E S H Chu; D Liu; A C-S Yu; T F Chan; X Li; J J Y Sung; V W S Wong; J Yu
Journal:  Oncogene       Date:  2016-05-02       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.